FDAnews
www.fdanews.com/articles/179555-medtronic-wins-ce-mark-expansion-for-endurant-iiiis

Medtronic Wins CE Mark Expansion for Endurant II/IIs

December 7, 2016

The European Union expanded Medtronic’s CE Mark for Endurant II/IIs stent graft for treating abdominal aortic aneurysms.

The update includes an implantation method called ChEVAR, which utilizes an expandable balloon to increase the artery area.

This expanded indication also allows the device to be used in aneurysm patients with short aortic neck length as small as 2mm, down from 10mm previously. — Cynthia Jessup

View today's stories